August 05, 2021 article Open access The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review Cancers DOI: 10.3390/cancers13163949 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 499 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Reduced colony‐stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression 2026 British Journal of Haematology article Medicine Chronic Lymphocytic Leukemia Research Open access 0 citations Stemness and Survival: CD117+/CD133+ Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal Melanoma 2026 Cells article Medicine Cancer Cells and Metastasis Open access 0 citations CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance 2024 Cells article Biochemistry, Genetics and Molecular Biology PI3K/AKT/mTOR signaling in cancer Open access 13 citations 3 results References 0